Cano Health (CANO) Misses Q4 EPS by 49c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall St set for lower open as Alphabet results reignite AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts CANO Hot Sheet
Join SI Premium – FREE
Cano Health (NYSE: CANO) reported Q4 EPS of ($0.61), $0.49 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $680.37 million versus the consensus estimate of $651.64 million.
GUIDANCE:
Cano Health sees FY2023 revenue of $3.1-3.25 billion, versus the consensus of $3.26 billion.
For earnings history and earnings-related data on Cano Health (CANO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stagwell Inc (STGW) Tops Q3 EPS by 3c ; Offers Guidance
- Altria raises guidance as Q3 earnings beat estimates
- West Bancorporation (WTBA) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
